About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 117 record(s)
Req # A-2023-001213
Screenshot of the status page for the Second Liraglutide Abbreviated New Drug Submission (ANDS) on the Drug Submission Tracking System (DSTS) interface.Organization: Health Canada
March 2024
Req # A-2023-000917
Adverse Drug Reaction (ADR). Report number: E2B_06425030.Organization: Health Canada
March 2024
Req # A-2023-000924
Adverse Drug Reaction (ADR). Report number: E2B_06027460.Organization: Health Canada
March 2024
Req # A-2023-001191
Adverse Drug Reaction (ADR). Report number: E2B_06621910.Organization: Health Canada
March 2024
Req # A-2023-001224
Adverse Drug Reaction (ADR). Report number: E2B_06648009.Organization: Health Canada
March 2024
Req # A-2023-001282
Adverse Drug Reaction (ADR). Report number: E2B_06615914.Organization: Health Canada
March 2024
Req # A-2023-001314
Adverse Drug Reactions (ADRs). Report numbers: E2B_06757446, E2B_06760973.Organization: Health Canada
March 2024
Req # A-2019-001941
Letters, notices, and email correspondence issued to Cannabis Act licence holders regarding non-compliance with the promotion prohibitions under the Cannabis Act between January 1, 2019 and February 1, 2020.Organization: Health Canada
March 2023
Req # A-2021-001315
Summary basis of decision and Instruction For Use (IFU) for Mirasol Pathogen Reduction Technology System model No. 106324.Organization: Health Canada
March 2023
Req # A-2022-001068
All internal or external evaluations about the effectiveness, efficiency, and equity of work performed by teleworkers and hybrid workers from the period of March 1, 2020 to November 1, 2022. Any manuals, guidelines, written policies, procedures and practices that your organization has developed for tele, hybrid, and on-site work for public servants since 2020. All documents that show the number of employees by their work status in March 2020, November 2021 and November 2022.Organization: Health Canada
March 2023